Firsthand Capital Management, Inc. Cyto Dyn Inc. Transaction History
Firsthand Capital Management, Inc.
- $47.5 Million
- Q4 2024
Shares
2 transactions
Others Institutions Holding CYDY
# of Institutions
10Shares Held
275KCall Options Held
0Put Options Held
0-
Diversified Trust CO45.8KShares$10,9890.0% of portfolio
-
Williams Jones Wealth Management, Llc. New York, NY45KShares$10,8000.0% of portfolio
-
Virtue Capital Management, LLC Brentwood, TN45KShares$10,8000.0% of portfolio
-
Rfp Financial Group LLC Atlanta, GA41.5KShares$9,9480.0% of portfolio
-
Next Capital Management LLC32.5KShares$7,8000.0% of portfolio
About CytoDyn Inc.
- Ticker CYDY
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 813,040,000
- Market Cap $195M
- Description
- CytoDyn Inc. operates as a clinical-stage biotechnology company. The company focuses on developing treatments for multiple therapeutic indications based on leronlimab, a novel humanized monoclonal antibody targeting the CCR5 receptor in the areas of human immunodeficiency virus (HIV), non-alcoholic steatohepatitis (NASH), oncology, and such as c...